STOCK TITAN
  1. Home
  2. Financials
  3. LPTX
  4. EPS (Diluted)

Leap Therapeutics, Inc. (LPTX) EPS by Year

LPTX

Leap Therapeutics, Inc. earned $0.07 per diluted share in fiscal year 2025. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Leap Therapeutics, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) $0.07
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LPTX EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20FY19FY18FY17FY16
EPS (Diluted)$0.07-$1.81-$3.98-$4.82-$0.47-$0.63-$1.47-$2.11+36.3%-$3.31N/A

LPTX EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
EPS (Diluted)-$0.46N/A-$0.08+81.8%-$0.40+23.1%-$0.37N/A-$0.44-$0.52-$0.51N/A-$0.51-$0.91

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Leap Therapeutics, Inc. financials

Frequently Asked Questions

What was Leap Therapeutics, Inc.'s diluted earnings per share in fiscal year 2025?

Leap Therapeutics, Inc. earned $0.07 per diluted share in fiscal year 2025.

What was Leap Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?

Leap Therapeutics, Inc. (LPTX) reported -$0.46 in diluted earnings per share in Q1 2026.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Leap Therapeutics, Inc. (LPTX) reported on that line in every period on record.